SOURCE: BioMedical Technology Solutions Holdings

June 11, 2009 11:18 ET

BMTS Signs National Distribution Agreement With Physicians Alliance of America

ENGLEWOOD, CO--(Marketwire - June 11, 2009) - BioMedical Technology Solutions Holdings, Inc. (OTCBB: BMTL) is pleased to announce the signing of a national distribution partnership with Physician Alliance of America (Norcross, GA) for the sale and distribution of the Demolizer® II System.

"We are excited to partner with BMTS in offering the Demolizer II to our members at a great price," said Bob Chalmers, Executive Director, Physicians Alliance of America (PAA). Chalmers further explains the philosophy behind Physicians Alliance and why they feel it is such a good fit with BMTS.

"Physicians Alliance of America, where Good Medicine Meets Good Business, is a nonprofit group purchasing organization formed in 1992 by 4 doctors concerned about the rising costs of running a practice. By providing free access to preferred pricing and terms on a full range of goods and services, PAA has grown to now serve well over 13,000 physicians in private practices across the country."

"The Demolizer II is a fantastic addition to the goods and services we offer our members. We are constantly looking for better systems and products for our members. I read about the Demolizer II receiving the Frost & Sullivan 2009 North American Product Innovation of the Year Award, and after further due diligence I realized this would be a great addition to our program. The Demolizer is an affordable, effective, and 'green' technology that saves practices money and insulates them from major price increases by biomedical waste haulers while providing the best long term solution to their disposal requirements! This means fewer headaches for our member practices."

"This is an import and strategic alignment for BMTS and Physicians Alliance of America," said Tom Von Bank BMTS' National Director of Sales. Further stating, "This partnership provides direct access to PAA's members allowing us the ability to introduce, on a much larger scale, the benefits of Demolizer II. Every physician within their organization is dealing with the regulatory reality associated with biomedical waste disposal. They now have access to the best technology available that simply and safely converts infectious waste on-site into ordinary garbage. Considering today's economic climate the Demolizer II System addresses the importance of cost savings while improving every aspect of their facilities biomedical waste disposal. We look forward to delivering the highest level of customer service and satisfaction to each PAA member."

About BioMedical Technology Solutions Holdings, Inc.

BioMedical Technology Solutions Holdings, Inc., located in Englewood, Colorado sells the Demolizer® II through its wholly owned subsidiary BioMedical Technology Solutions, Inc. BMTS' patented Demolizer® Technology converts infectious biomedical waste into non-infectious material. BMTS' products provide biomedical waste treatment solutions for the over 1,000,000 low to medium volume medical waste generators in the US and a global market five times larger than the US. For more information, visit or call 866-525-2687.

About the Demolizer® II

The Demolizer ® II is the GREEN alternative to biomedical waste disposal. The device is the only patented, portable, and self-contained system able to process both sharps and typical red bag biomedical waste onsite. The processed waste is rendered sterile and discarded as common trash eliminating up to 100% of the cost associated with its disposal. The Demolizer® II meets or exceeds all EPA and CDC guidelines and is approved or meets treatment requirements in 47 states after review by 78 governmental agencies. The device uses no chemicals or liquids, plugs into a normal outlet through a surge protector, and automatically records and prints state required documentation. The Demolizer® II provides a safer, more environmentally GREEN method for biomedical waste disposal.

Safe Harbor for Forward-Looking Statements

The statements contained in this press release may include certain projections and forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve a number of risks and uncertainties. Such statements reflect the Company's current views with respect to future events and financial performance. No assurances can be given however, that these events will occur or that such expectations will be achieved and that actual results could differ materially from those described. Actual results of future operations of BioMedical Technology Solutions Holdings, Inc. may differ materially from those indicated by these forward-looking statements as a result of various important factors.

Contact Information

  • For more information:
    BioMedical Technology Solutions Holdings, Inc.

    David A. Kempf
    BioMedical Technology Solutions Holdings, Inc.